计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
M158689-1g |
1g |
现货 ![]() |
| |
M158689-5g |
5g |
现货 ![]() |
| |
M158689-25g |
25g |
现货 ![]() |
| |
M158689-100g |
100g |
现货 ![]() |
|
别名 | 米诺地尔 | 6-(1-哌啶基)-2,4-嘧啶二胺 3-氧化物 | 6-(1-哌啶基)嘧啶-2,4-二胺 3-氧化物 | 2,6-二氨基-4-哌啶基嘧啶1-氧化物 |
---|---|
英文别名 | pyrimidin-1(2H)-ol | Women''''s rogaine | 3-hydroxy-2-imino-6-piperidin-1-ylpyrimidin-4-amine | SCHEMBL29698 | Spectrum3_000509 | 2,4-Diamino-6-piperidinopyrimidine 3-oxide | 3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine | Minoxidil (U-10858) | U-10, |
规格或纯度 | Moligand™, ≥98%(HPLC)(T) |
英文名称 | Minoxidil |
生化机理 | 降压药。抗脱发剂。Kir6通道(KATP)激活剂。 |
应用 | Minoxidil has been used as test drug: · in dermal papilla spheroid model, to study the effectof hair regeneration · administered orally to experimental rats, in theapproach to identify biomarkers of drug induced vascular injury · administered via oral gavage to nonhuman primate modelin order to study its effect on tilt responses |
运输条件 | 常规运输 |
作用类型 | 激活剂 |
作用机制 | K ir6.1 激活因子;K ir6.2 激活因子 |
产品介绍 |
米诺地尔作为测试药物:应用于真皮乳头球体模型中,旨在研究头发再生效果;口服给大鼠,识别药物诱导血管损失的生物标志物;口服灌胃非人灵长类动物模型,研究其对倾斜反应的效果
Minoxidil is used as antihypertensive, antialopecia agent. . It is administered orally for the treatment of severe hypertension and used topically to promote the regrowth of hair in male and female pattern baldness.
|
PubChem SID | 488179821 |
---|---|
IUPAC Name | 3-hydroxy-2-imino-6-piperidin-1-ylpyrimidin-4-amine |
INCHI | InChI=1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6,11,15H,1-5,10H2 |
InChi Key | ZIMGGGWCDYVHOY-UHFFFAOYSA-N |
Canonical SMILES | C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O |
Isomeric SMILES | C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O |
WGK Germany | 3 |
RTECS | UV8200000 |
PubChem CID | 4201 |
分子量 | 209.25 |
Beilstein号 | 25(5)12,317 |
Reaxy-Rn | 886240 |
溶解性 | 溶于ethanol, 最高浓度 (mg/mL): 5.23, 最高浓度(mM): 25;溶于DMSO, 最高浓度 (mg/mL): 5.23, 最高浓度(mM): 25 温和加热 |
---|---|
熔点 | 272-274 °C |
分子量 | 209.250 g/mol |
XLogP3 | 1.200 |
氢键供体数Hydrogen Bond Donor Count | 3 |
氢键受体数Hydrogen Bond Acceptor Count | 3 |
可旋转键计数Rotatable Bond Count | 1 |
精确质量Exact Mass | 209.128 Da |
单同位素质量Monoisotopic Mass | 209.128 Da |
拓扑极表面积Topological Polar Surface Area | 88.900 Ų |
重原子数Heavy Atom Count | 15 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 329.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
象形图 | GHS08, GHS07 |
---|---|
信号词 | Warning |
危险声明 |
H315: 引起皮肤刺激 H319: 引起严重眼睛刺激 H335: 可能引起呼吸道刺激 H351: 怀疑引起遗传缺陷 H302: 吞食有害 H361: 怀疑破坏生育力或未出生的孩子 |
预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P302+P352: 如皮肤沾染:用水充分清洗。 P321: 特殊处理(请参阅此标签上的...)。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P264: 处理后要彻底洗手。 P271: 仅在室外或通风良好的地方使用。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。 P403+P233: 存放在通风良好的地方。保持容器密闭。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。 P330: 漱口 P203: 使用前,获取、阅读并遵守所有安全说明。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P301+P317: 如果被吞咽:请寻求医疗帮助。 P318: 如果暴露或担心,请就医。 P337+P317: 如果眼睛刺激持续:寻求医疗帮助。 P332+P317: 如果出现皮肤刺激:请寻求医疗帮助。 P319: 如果你感到不适,请寻求医疗帮助。 |
WGK Germany | 3 |
RTECS | UV8200000 |
Reaxy-Rn | 886240 |
Merck Index | 6203 |
个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
Purity(NonaqueousTitration) | 97.5-102.5(%) |
---|---|
Purity(HPLC) | 98-100(%) |
Appearance(M158689) | White to Light Yellow Powder or Crystals |
Proton NMR spectrum | Conforms to Structure |
Solubility in EtOH,Colorless to Light Yellow,Clear to Hazy,10mg/mL | Pass |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
批号(Lot Number) | 证书类型 | 日期 | 货号 |
---|---|---|---|
![]() |
分析证书 | 24-03-15 | M158689 |
![]() |
分析证书 | 24-03-15 | M158689 |
![]() |
分析证书 | 24-03-15 | M158689 |
![]() |
分析证书 | 24-01-18 | M158689 |
![]() |
分析证书 | 24-01-18 | M158689 |
![]() |
分析证书 | 24-01-18 | M158689 |
![]() |
分析证书 | 24-01-18 | M158689 |
![]() |
分析证书 | 23-02-01 | M158689 |
![]() |
分析证书 | 23-02-01 | M158689 |
![]() |
分析证书 | 23-02-01 | M158689 |
![]() |
分析证书 | 23-02-01 | M158689 |
![]() |
分析证书 | 23-02-01 | M158689 |
![]() |
分析证书 | 23-02-01 | M158689 |
![]() |
分析证书 | 23-02-01 | M158689 |
![]() |
分析证书 | 23-02-01 | M158689 |
![]() |
分析证书 | 22-01-22 | M158689 |
![]() |
分析证书 | 21-11-22 | M158689 |
![]() |
分析证书 | 21-11-22 | M158689 |
1. Yu Cai, Liying Xin, Hui Li, Peng Sun, Chao Liu, Liang Fang. (2024) Mussel-inspired controllable drug release hydrogel for transdermal drug delivery: Hydrogen bond and ion-dipole interactions. JOURNAL OF CONTROLLED RELEASE, 365 (24): (161). [PMID:37972766] [10.1016/j.jconrel.2023.11.016] |
2. Peixin Li, Yanfang Sun, Lei Nie, Amin Shavandi, Khaydar E. Yunusov, Yinjian Hua, Guohua Jiang. (2023) Fabrication of carboxymethyl cellulose/hyaluronic acid/polyvinylpyrrolidone composite pastes incorporation of minoxidil-loaded ferulic acid-derived lignin nanoparticles and valproic acid for treatment of androgenetic alopecia. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 249 (126013). [PMID:37517761] [10.1016/j.ijbiomac.2023.126013] |
3. Meirong Yin, Yongnian Zeng, Han-Qing Liu, Wen Zhang, Chenyuan Wang, Chuang Chen, Wei Li. (2023) Dissolving Microneedle Patch Integrated with Microspheres for Long-Acting Hair Regrowth Therapy. ACS Applied Materials & Interfaces, 15 (14): (17532–17542). [PMID:36975753] [10.1021/acsami.2c22814] |
4. Qi Tian, Peng Quan, Liang Fang, Hui Xu, Chao Liu. (2021) A molecular mechanism investigation of the transdermal/topical absorption classification system on the basis of drug skin permeation and skin retention. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 608 (121082). [PMID:34506925] [10.1016/j.ijpharm.2021.121082] |
1. Yushu Chen a , Shouwen Jin a,* , Yutao Chen a , Xingjun Gao a,* , Xusen Gong a , Linfang Shi b , Hui Liu a , Xiaodan Ma a,b , Daqi Wang c. (2024) 2D-3D supramolecular systems assemblied from minoxidil and organic acids: Preparation, spectral, crystallographic characterization and Hirshfeld surface analysis . Journal of Molecular Structure, 1302 (1302): (137353). [https://doi.org/10.1016/j.molstruc.2023.137353 ] |
2. Yu Cai, Liying Xin, Hui Li, Peng Sun, Chao Liu, Liang Fang. (2024) Mussel-inspired controllable drug release hydrogel for transdermal drug delivery: Hydrogen bond and ion-dipole interactions. JOURNAL OF CONTROLLED RELEASE, 365 (24): (161). [PMID:37972766] [10.1016/j.jconrel.2023.11.016] |
3. Peixin Li, Yanfang Sun, Lei Nie, Amin Shavandi, Khaydar E. Yunusov, Yinjian Hua, Guohua Jiang. (2023) Fabrication of carboxymethyl cellulose/hyaluronic acid/polyvinylpyrrolidone composite pastes incorporation of minoxidil-loaded ferulic acid-derived lignin nanoparticles and valproic acid for treatment of androgenetic alopecia. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 249 (126013). [PMID:37517761] [10.1016/j.ijbiomac.2023.126013] |
4. Meirong Yin, Yongnian Zeng, Han-Qing Liu, Wen Zhang, Chenyuan Wang, Chuang Chen, Wei Li. (2023) Dissolving Microneedle Patch Integrated with Microspheres for Long-Acting Hair Regrowth Therapy. ACS Applied Materials & Interfaces, 15 (14): (17532–17542). [PMID:36975753] [10.1021/acsami.2c22814] |
5. Qi Tian, Peng Quan, Liang Fang, Hui Xu, Chao Liu. (2021) A molecular mechanism investigation of the transdermal/topical absorption classification system on the basis of drug skin permeation and skin retention. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 608 (121082). [PMID:34506925] [10.1016/j.ijpharm.2021.121082] |